Jack Taylor

Clinical Scientist

Jack joined Actinogen in February 2020, bringing a deep understanding of pharmaceutical science and a passion for novel drug discovery research. 

Jack obtained his Bachelor of Science in Neuroscience and Physiology at the University of Sydney in 2011 and a Master of Pharmacy at the University of Technology (UTS) in 2015. He recently completed his PhD at UTS in the laboratory of Cancer Cell Biology and Therapeutics.  Using a combination of molecular, imaging, and analytical techniques, Jack’s research focused on the biogenic pathways of extracellular vesicles. Specifically, his research discovered there are discrete molecular pathways that regulate extracellular vesicle biogenesis in malignant and non-malignant cells – identifying new potential strategies to circumvent multidrug resistance in cancer.

LinkedIn Profile: https://www.linkedin.com/in/jack-taylor-3589b4145